Herein we sought to establish, by reverse modeling of SMARCB1 loss through the re-introduction of SMARCB1 into malignant rhabdoid tumors cell lines representative of MRTK (G401) and ATRT (BT16), just how dysregulation of the chromatin landscape could contribute to oncogenesis. This evidence concerns the gene SMARCB1 and rhabdoid tumor.